Lv1
10 积分 2021-03-24 加入
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion
5小时前
待确认
A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease
5小时前
已完结
Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial
7个月前
已完结
A study on the efficacy and safety of anlotinib in patients with metastatic pheochromocytoma and paraganglioma
8个月前
已关闭
The preliminary efficacy and safety results of neoadjuvant phase 2 study of penpulimab combined with taxanes and carboplatin in triple-negative breast cancer (neoTAPPL)
8个月前
已关闭
Cancer incidence and mortality in China, 2022
8个月前
已完结
[Chinese expert consensus on multidisciplinary diagnosis and treatment of radiation rectal injury (2021 edition)]
10个月前
已完结
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial
11个月前
已完结
皖公网安备34019202002308
